Список литературы

1. Адамян Л.В. Состояние репродуктивной системы у больных доброкачественными опухолями внутренних гениталий и принципы восстановительного лечения: Дис. ... д-ра мед. наук//Москва. - 1985. Москва.

2. El-Balat A. et al. Modern Myoma Treatment in the Last 20 Years: A Review of the Literature//BioMed research international. - 2018. - T. 2018.

3. F.R. et al. EMAS position statement: management of uterine fibroids//Maturitas. - 2014. - Т. 79. - N. 1. - С. 106 - 116.

4. Kubik-Huch R.A. et al. European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas//European radiology. - 2018. - Т. 28. - N. 8. - С. 312 - 3137.

5. Grings A.O. et al. Protein expression of estrogen receptors and and aromatase in myometrium and uterine leiomyoma//Gynecologic and obstetric investigation. - 2012. - Т. 73. - N. 2. - С. 113 - 117.

6. He C, Nelson W et al. Frequency of MED12 Mutation in Relation to Tumor and Patient's Clinical Characteristics: a Meta-analysis. Reprod Sci. 2022 Feb; 29(2): 357 - 365.

7. Markowski D.N. et al. HMGA2 and p14Arf: major roles in cellular senescence of fibroids and therapeutic implications//Anticancer research. - 2011. - Т. 31. - N. 3. - С. 753 - 761.

8. Ciavattini A. et al. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction//Obstetrics and gynecology international. - 2013. - Т. 2013.

9. Mittal P. et al. Med12 gain-of-function mutation causes leiomyomas and genomic instability//The Journal of clinical investigation. - 2015. - Т. 125. - N. 8. - С. 3280 - 3284.

10. Osinovskaya N.S. et al. Frequency and spectrum of MED12 exon 2 mutations in multiple versus solitary uterine leiomyomas from Russian patients//International journal of gynecological pathology. - 2016. - Т. 35. - N. 6. - С. 509 - 515.

11. Tal R., Segars J.H. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy//Human reproduction update. - 2013. - Т. 20. - N. 2. - С. 194 - 216.

12. Сидорова И.С. и др. Современное состояние вопроса о патогенезе, клинике, диагностике и лечении миомы матки у женщин репродуктивного возраста//Акушерство, гинекология и репродукция. - 2012. - Т. 6. - N. 4.

13. Ren Y. et al. Different effects of epidermal growth factor on smooth muscle cells derived from human myometrium and from leiomyoma//Fertility and sterility. - 2011. - Т. 96. - N. 4. - С. 1015 - 1020. e1.

14. Plewka D. et al. Expression of VEGF isoforms and their receptors in uterine myomas//Ginekologia polska. - 2016. - Т. 87. - N. 3. - С. 166 - 177.

15. Q Yang et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment//Endocr Rev, 2022 Jul 13; 43(4): 678 - 719.

16. C Millien et al. Assessing burden, risk factors, and perceived impact of uterine fibroids on women's lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study//Int J Equity Health 2021.

17. Pavone D. et al. Epidemiology and risk factors of uterine fibroids//Best Practice & Research Clinical Obstetrics & Gynaecology. - 2018. - Т. 46. - С. 3 - 11.

18. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstet Gynecol. 2021 Jun 1; 137(6): e100 - e115. doi: 10.1097/AOG.0000000000004401.

19. Серов В.Н., Сухих Г.Т. Клинические рекомендации. Акушерство и гинекология//М: ГЭОТАР-Медиа. - 4-е изд. - 2017. Москва: Проблемы репродукции.

20. Donnez J., Donnez O., Dolmans M.M. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?//Fertility and Sterility. - 2014. - Т. 102. - N. 3. - С. 640 - 648.

21. Worldwide A.A. M. I. G. AAGL practice report: practice guidelines for the management of hysteroscopic distending media: (replaces hysteroscopic fluid monitoring guidelines. J Am Assoc Gynecol Laparosc. 2000; 7: 167 - 168.)//Journal of minimally invasive gy.

22. SOGC clinical practice guideline, The Management of Uterine Leiomyomas, No. 318.

23. Stewart E.A. et al. Epidemiology of uterine fibroids: a systematic review//BJOG: An International Journal of Obstetrics & Gynaecology. - 2017. - Т. 124. - N. 10. - С. 1501 - 1512.

24. Zepiridis L.I., Grimbizis G.F., Tarlatzis B.C. Infertility and uterine fibroids//Best Practice & Research Clinical Obstetrics & Gynaecology. - 2016. - Т. 34. - С. 66 - 73.

25. Parazzini F., Tozzi L., Bianchi S. Pregnancy outcome and uterine fibroids//Best practice & research Clinical obstetrics & gynaecology. - 2016. - Т. 34. - С. 74 - 84.

26. Munro M.G. et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age//International Journal of Gynecology & Obstetrics. - 2011. - Т. 113. - N. 1. - С. 3 - 13.

27. Munro M.G. et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions//International Journal of Gynecology & Obstetrics. - 2018. - Т.

28. Suzuki A. et al. Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma Using Magnetic Resonance Images: A Literature Review//Healthcare. - Multidisciplinary Digital Publishing Institute, 2019. - Т. 7. - N. 4. - С. 158.

29. Савельева Г.М. и др. Национальное руководство//Акушерство-М.: Гэотар-Медиа. - 2015.

30. Marret H. et al. Therapeutic management of uterine fibroid tumors: updated French guidelines//European Journal of Obstetrics & Gynecology and Reproductive Biology. - 2012. - Т. 165. - N. 2. - С. 156 - 164.

31. Fascilla F.D. et al. Ultrasound diagnosis of uterine myomas//Minerva ginecologica. - 2016. - Т. 68. - N. 3. - С. 297 - 312.

32. Minsart A.F. et al. Does three-dimensional power Doppler ultrasound predict histopathological findings of uterine fibroids? A preliminary study//Ultrasound in obstetrics & gynecology. - 2012. - Т. 40. - N. 6. - С. 714 - 720.

33. Levine D.J. et al. Sensitivity of myoma imaging using laparoscopic ultrasound compared with magnetic resonance imaging and transvaginal ultrasound//Journal of minimally invasive gynecology. - 2013. - Т. 20. - N. 6. - С. 770 - 774.

34. Yang T. et al. Sonohysterography: Principles, technique and role in diagnosis of endometrial pathology//World journal of radiology. - 2013. - Т. 5. - N. 3. - С. 81.

35. A., S. Ultrasonography of uterine leiomyomas//Przeglad menopauzalny= Menopause review. - 2017. - Т. 16. - N. 4. - С. 113.

36. Dueholm M. et al. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas//American journal of obstetrics and gynecology. - 2002. - Т. 186. - N. 3. - С. 409 - 415.

37. Martucci C et al. Uterine leiomyoma in pediatric population: A case report and review of the literature. Front Pediatr. 2022.

38. Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020.

39. David DA, Rodrigues , Amaral J, Geraldes F. Submucous leiomyoma: an uncommon cause of heavy menstrual bleeding in early adolescence. BMJ Case Rep. 2024.

40. De La Cruz M.S., Buchanan E.M. Uterine fibroids: diagnosis and treatment//Am Fam Physician. - 2017. - Т. 95. - N. 2. - С. 100 - 107.

41. Donnez J., Dolmans M.M. Uterine fibroid management: from the present to the future//Human Reproduction Update. - 2016. - Т. 22. - N. 6. - С. 665 - 686.

42. Barcelos N. B. et al. Clinicopathological study of cystic and atypical uterine leiomyoma: a rare entity//Jornal Brasileiro de Patologia e Medicina Laboratorial. - 2021.

43. Ciccarone F. et al. Diagnosis of uterine leiomyosarcoma 5 years after magnetic-resonance-guided high-intensity focused ultrasound treatment of fibroid//Ultrasound in Obstetrics & Gynecology. - 2022.

44. Takeda A., Koike W., Watanabe K. Multimodal imaging for diagnosis and management of parasitic peritoneal myoma with myxoid degeneration after laparoscopic-assisted myomectomy with electric power morcellation//Journal of Obstetrics and Gynaecology Researc.

45. Roberts M.E., Aynardi J.T., Chu C.S. Uterine leiomyosarcoma: A review of the literature and update on management options//Gynecologic oncology. - 2018.

46. Eder S. et al. Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids//Women's health. - 2013. - Т. 9. - N. 4. - С. 397 - 403.

47. Bitzer J. et al. Medical management of heavy menstrual bleeding: a comprehensive review of the literature//Obstetrical & gynecological survey. - 2015. - Т. 70. - N. 2. - С. 115 - 130.

48. Lukes A.S. et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial//Obstetrics & Gynecology. - 2010. - Т. 116. - N. 4. - С. 865 - 875.

49. Bryant-Smith, A.C. Antifibrinolytics for heavy menstrual bleeding/A.C. Bryant-Smith, A. Lethaby, C. Farquhar, M. Hickey//Cochrane Database Syst Rev. - 2018. - Issue 4.

50. The Royal Children's Hospital, Melbourne, Australia, Clinical Practice Guideline on Adolescent gynaecology - Heavy menstrual bleeding [Internet, last updated August 2020.

51. Naoulou, B. Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review//B. Naoulou, M.C. Tsai//Acta Obstet Gynecol Scand. - 2012. - vol. 91. - N 5. - P. 529 - 537.

52. Синчихин С.П. и др. Дисменорея - современный взгляд на этиологию, патогенез, диагностику, клинику и лечение (обзор литературы)//Астраханский медицинский журнал. - 2010.

53. Lethaby A., Duckitt K., Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding//Cochrane database of systematic reviews. - 2013. - N. 1.

54. Ichigo S. et al. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist//Archives of gynecology and obstetrics. - 2011. - Т. 284. - N. 3. - С. 667 - 670.

55. Bofill Rodriguez M, Lethaby A, Jordan V. Progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2020.

56. Heavy menstrual bleeding: assessment and management NICE guideline [NG88] Published date: 14 March 2018 Last updated: 31 March 2020.

57. De Silva N 2019, Abnormal uterine bleeding in adolescents: Management [Internet]. UpToDate. Available from: https://www.uptodate.com/contents/abnormal-uterine-bleeding-in-adolescents-management.

58. Bofill M.R. et al. Cyclical progestogens for heavy menstrual bleeding//The Cochrane database of systematic reviews. - 2019. - Т. 8. - С. CD001016 - CD001016.

59. Lethaby A., Puscasiu L., Vollenhoven B. Preoperative medical therapy before surgery for uterine fibroids//Cochrane Database of Systematic Reviews. - 2017. - N. 11.

60. Qin J. et al. Oral contraceptive use and uterine leiomyoma risk: a meta-analysis based on cohort and case-control studies//Archives of gynecology and obstetrics. - 2013. - Т. 288. - N. 1. - С. 139 - 148.

61. Mas A. et al. Updated approaches for management of uterine fibroids//International journal of women's health. - 2017. - Т. 9. - С. 607.

62. Zhang Y. et al. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis//Obstetrical & gynecological survey. - 2014. - Т. 69. - N. 2. - С. 100 - 108.

63. P Laberge, A Murji, G A. Vilos, C Allaire, N Leyland, S Singh Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas//Journal of Obstetrics and Gynaecology Canada V 41, I 10, 2019.

64. Tristan M. et al. Mifepristone for uterine fibroids//Cochrane Database of Systematic Reviews. - 2012. - N. 8.

65. Тихомиров А.Л., Деды Т.В. и др. Актуальная стратегия ведения пациенток с миомой матки в амбулаторных условиях//Трудный пациент. 2021. N 4.

66. M Engman, S Granberg, A R W Williams, C X Meng, P G L Lalitkumar, K Gemzell-Danielsson Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial//Hum Reprod, 2009.

67. J Steinauer, E A Pritts, R Jackson, A F Jacoby Systematic review of mifepristone for the treatment of uterine leiomyomata//Obstet Gynecol, 2004.

68. A Murji, L Whitaker, T L Chow, M L Sobel Selective progesterone receptor modulators (SPRMs) for uterine fibroids//Cochrane Database Syst Rev, 2017.

69. Gupta M. et al. A prospective interventional study to evaluate the effects of medical therapy (Mifepristone 25 mg) on the management of uterine fibroids//Journal of Family Medicine and Primary Care. - 2020.

70. Chittawar P. B. et al. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids//Cochrane Database of Systematic Reviews. - 2014. - N. 10.

71. Sandberg E. M. et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis//Fertility and sterility. - 2018. - Т. 109. - N. 4. - С. 698 - 707. e1.

72. Kongnyuy E.J., Wiysonge C.S. Interventions to reduce haemorrhage during myomectomy for fibroids//Cochrane Database of Systematic Reviews. - 2014. - N. 8. John Wiley & Sons, Ltd.

73. ACOG. Leiomyomas P. Uterine Morcellation for Presumed Leiomyomas. - 2019.

74. Gkrozou F. et al. Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies//Archives of gynecology and obstetrics. - 2015. - Т. 291. - N. 6. - С. 1347 - 1354.

75. Yin X. et al. Hysteroscopic tissue removal systems for the treatment of intrauterine pathology: a systematic review and meta-analysis//Facts, views & vision in ObGyn. - 2018. - Т. 10. - N. 4. - С. 207.

76. Sesti F. et al. Randomized comparison of total laparoscopic, laparoscopically assisted vaginal and vaginal hysterectomies for myomatous uteri//Archives of gynecology and obstetrics. - 2014. - Т. 290. - N. 3. - С. 485 - 491.

77. "Fonseca M.C.M. et al. Uterine artery embolization and surgical methods for the treatment of symptomatic uterine leiomyomas: a systemic review and meta-analysis followed by indirect treatment comparison//Clinical therapeutics. - 2017. - Т. 39. - N. 7. - ," doi: 10.1016/j.clinthera.2017.05.346.

78. Gupta J.K. et al. Uterine artery embolization for symptomatic uterine fibroids//Cochrane Database of Systematic Reviews. - 2014. - N. 12. John Wiley & Sons, Ltd.

79. Czuczwar P. et al. Comparison of the influence of three fibroid treatment options: Supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve - an observational study//Journal of ovarian research. - 2018. - Т. 11. - N.

80. Quinn S.D. et al. Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids//European Journal of Obstetrics & Gynecology and Reproductive Biology. - 2014. - Т. 182. - С. 247 - 251., vol. 182.

81. Rabinovici J. et al. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids//Fertility and sterility. - 2010. - Т. 93. - N. 1. - С. 199 - 209.

82. Кравченко Е.Н. и др. Реабилитация после гинекологических операций в репродуктивном возрасте//Мать и дитя в Кузбассе. - 2019.

83. Дугиева М.З. Оптимизация физиотерапевтических технологий в ранней реабилитации больных после операций по поводу миомы матки. автореферат диссер. док. мед. наук//Москва. - 2015.

84. Favilli A. et al. Impact of FIGO type 3 uterine fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis//International Journal of Gynecology & Obstetrics. - 2023.

85. Pritts E. A. Fibroids and infertility: a systematic review of the evidence//Obstetrical & gynecological survey. - 2001. - Т. 56. - N. 8.

86. Carranza-Mamane B. et al. The management of uterine fibroids in women with otherwise unexplained infertility//Journal of Obstetrics and Gynaecology Canada. - 2015. - Т. 37. - N. 3. - С. 277 - 285.

87. Milazzo G.N. et al. Myoma and myomectomy: Poor evidence concern in pregnancy//Journal of Obstetrics and Gynaecology Research. - 2017.

88. Radosa M.P. et al. Laparoscopic myomectomy in peri - and post-menopausal women is safe, efficacious and associated with long-term patient satisfaction//European Journal of Obstetrics & Gynecology and Reproductive Biology. - 2012. - Т. 162. - N. 2. - С. 19.

89. Ulin M. et al. Uterine fibroids in menopause and perimenopause//Menopause. - 2019.

90. Lethaby A.E., Vollenhoven B.J. An evidence-based approach to hormonal therapies for premenopausal women with fibroids//Best Practice & Research Clinical Obstetrics & Gynaecology. - 2008. - Т. 22. - N. 2. - С. 307 - 331.

91. Kaganov H., Ades A., Fraser D.S. Preoperative magnetic resonance imaging diagnostic features of uterine leiomyosarcomas: a systematic review//International journal of technology assessment in health care. - 2018. - Т. 34. - N. 2. - С. 172 - 179.

92. Ludovisi M. et al. Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma//Ultrasound in Obstetrics & Gynecology. - 2019. - Т. 54. - N. 5. - С. 676 - 687.